Navin Varadarajan

32PUBLICATIONS
118CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jul 30, 2025
TIGIT Affects CAR NK-cell Effector Function in the Solid Tumor Microenvironment by Modulating Immune Synapse Strength.

Ishwar Navin, Matthew Dysthe, Prashant S Menon

|Apr 29, 2025
Somatic TP53 Mutations Drive T and NK Cell Dysfunction in AML and Can be Rescued by Reactivating Wild Type p53.

Li Li, Muharrem Muftuoglu, Edward Ayoub

|Mar 24, 2025
Mesoscopic p53-rich clusters represent a new class of protein condensates.

David S Yang, Alexander Tilson, Michael B Sherman

|Jan 10, 2025
Molecular dynamics at immune synapse lipid rafts influence the cytolytic behavior of CAR T cells.

Ahmed Z Gad, Jessica S Morris, Lea Godret-Miertschin

|Nov 28, 2024
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers.

David Steffin, Nisha Ghatwai, Antonino Montalbano

|Jul 23, 2024
Multi-antigen intranasal vaccine protects against challenge with sarbecoviruses and prevents transmission in hamsters.

Ankita Leekha, Arash Saeedi, K M Samiur Rahman Sefat

Pageof 6